Cynapsus Overview
- Founded
- 2004

- Status
- Acquired/Merged
- Employees
- 30

- Latest Deal Type
- M&A
- Financing Rounds
- 10
- Investments
- 1
Cynapsus General Information
Description
Operator of a specialty central nervous system (CNS) pharmaceutical company. The company develops a sublingual thin film for the potential treatment for on-demand management of debilitating OFF episodes associated with Parkinson's disease. It also completed a Phase two clinical trial for its product candidate, APL-130277, a sublingual formulation of apomorphine hydrochloride, or apomorphine.
Contact Information
- 828 Richmond Street West
- Toronto, Ontario M6J 1C9
- Canada
Cynapsus Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Cynapsus‘s full profile, request access.
Request a free trialCynapsus Comparisons
Industry
0000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialCynapsus Competitors (26)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Axovant Sciences | Formerly VC-backed | New York, NY | 00 | 00000 | 00000000 | 00000 |
000000000000 00000 | Corporate Backed or Acquired | Trevose, PA | 00 | 00000 | 00000000000 | 00000 |
00000000 | Formerly VC-backed | Jersey City, NJ | 00 | 00000 | 000000000 | 00000 |
00000000 000000000 | Corporation | Givatayim, Israel | 0 | 000.00 | 000000000 | 000.00 |
0000 000000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00.000 | 000000000 | 00.000 |
Cynapsus Executive Team (6)
Cynapsus Board Members (10)
Name | Representing | Role | Since |
---|---|---|---|
0000000 0000000000 | Cynapsus | President, Chief Executive Officer and Director | 000 0000 |
000000000 00000000 | Self | Board Member | 000 0000 |
000 0000000000 | Cynapsus | Board Member | 000 0000 |
00000 00000000 00 | Cynapsus | Board Member | 000 0000 |
00000000 00000000 | Cynapsus | Chairman | 000 0000 |
Cynapsus Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialCynapsus Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Cynapsus‘s full profile, request access.
Request a free trialCynapsus Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000 00000000000 | 22-Dec-2011 | 000000000000000000 | 00.00 | Pharmaceuticals | 00000000 00000000 |